RT Journal Article
SR Electronic
T1 Review of Forecasting Models for Coronavirus (COVID-19) Pandemic in India during Country-wise Lockdowns
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.03.20167254
DO 10.1101/2020.08.03.20167254
A1 Abhinav Gola
A1 Ravi Kumar Arya
A1 Animesh
A1 Ravi Dugh
YR 2020
UL http://medrxiv.org/content/early/2020/08/11/2020.08.03.20167254.abstract
AB Background COVID-19 is widely spreading across the globe right now. While some countries have flattened the curve, others are struggling to control the spread of the infection. Precise risk prediction modeling is key to accurate prevention and containment of COVID-19 infection, as well as for the preparation of resources needed to deal with the pandemic in different regions.Methods Given the vast differences in approaches and scenarios used by these models to predict future infection rates, in this study, we compared the accuracy among different models such as regression models, ARIMA model, multilayer perceptron, vector autoregression, susceptible exposed infected recovered (SEIR), susceptible infected recovered (SIR), recurrent neural networks (RNNs), long short term memory networks (LSTM) and exponential growth model in prediction of the total COVID-19 confirmed cases. We did so by comparing the predicted rates of these models with actual rates of COVID-19 in India during the nationwide lockdowns.Results Few of these models accurately predicted COVID-19 incidence and mortality rates in six weeks, though some provided close results. While advanced warning can help mitigate and prepare for an impending or ongoing epidemic, using poorly fitting models for prediction could lead to substantial adverse outcomes.Implications As the COVID-19 pandemic continues, accurate risk prediction is key to effective public health interventions. Caution should be taken when choosing different risk prediction models based on specific scenarios and needs. To improve risk prediction of infectious disease such as COVID-19 for policy guidance and recommendations on best practices, both internal (e.g., specific virus characteristics in transmission and mutation) and external factors (e.g., large-scale human behaviors such as school opening, parties, and breaks) should be considered and appropriately weighed.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is already available in the paper's references.